comparemela.com

Amgen Epogen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FDA approves Akebia anemia pill, two years after rejection

BMS Cancer Drug s New FDA Nod Puts It on Path to Reach Blockbuster Status

Bristol Myers Squibb drug Reblozyl is now approved as a first-line therapy for anemia caused by myelodysplastic syndromes, a group of blood cancers. It’s the third indication for the drug, which analysts project could top $4 billion in peak sales.

Managing 3rd Party IP and Freedom to Operate in Drug Development | Procopio, Cory, Hargreaves & Savitch LLP

When it comes to product development, the management of third-party intellectual property (IP) to ensure freedom to operate is of paramount importance. Drug development is no different..

Flagship Startup Emerges to Find Drugs in Promising Hunting Ground—Our Bodies

Pfizer ups Epogen biosimilar deal with CDMO - BioProcess Insider

Pfizer ups Epogen biosimilar deal with CDMO - BioProcess Insider
bioprocessintl.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bioprocessintl.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.